Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open-label Clinical Study to Evaluate the Efficacy and Safety of NB003 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)

NCT07379047 is registered in ClinicalTrials.gov with Ningbo Newbay Technology Development Co., Ltd as lead sponsor.

NCT NCT07379047
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07379047 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open-label Clinical Study to Evaluate the Efficacy and Safety of NB003 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
Lead sponsor
Ningbo Newbay Technology Development Co., Ltd
Phase
Phase 2/3
Overall status
Recruiting
Start date
May 11, 2026
Completion date
September 1, 2028
Enrollment
255 (estimated)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

advanced, gist - gastrointestinal stromal tumor